PROVIDER PROFILE · NPI 1407016348
Ronald MittelM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
885
Unique beneficiaries
—
Total services
14,406
Distinct HCPCS
13
Medicare payment
$215K
Peer benchmark
Total Medicare services vs. 59 Allergy/ Immunology providers in AZ — above median (cohort median 9,793).
PRESCRIBING · PART D · 2024
Total Rx claims
1,252
Beneficiaries
—
Total drug cost
$608K
Distinct drugs
21
Brand share
37.6%
Top prescribed drugs
Azelastine Hcl308 claims
Albuterol Sulfate135 claims
Ipratropium Bromide124 claims
Montelukast Sodium123 claims
Dupilumab65 claims
QUALITY · MIPS · 2024
Final MIPS score
75.0
Quality
0.0
Cost
76.0
Improvement activities
0.0
Promoting interop.
0.0
Payment adjustment
0.00%
Individual
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$4K
Payment records
243
By payment type
Food and Beverage$4K
Consulting Fee$53
Top paying entities
Food and Beverage$4K
Consulting Fee$53
REFERRAL NETWORK
Where Ronald Mittel's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 2 outbound destinations.
Receives referrals from
Inbound — who sends patients here
No inbound pairs above the suppression threshold.
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Sonora Quest Laboratories Llc Clinical Laboratory · Phoenix, AZ | 35 | 210 |
| Laboratory Corporation Of America Clinical Laboratory · Phoenix, AZ | 18 | 83 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE